220 related articles for article (PubMed ID: 19214663)
21. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
[TBL] [Abstract][Full Text] [Related]
22. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
[TBL] [Abstract][Full Text] [Related]
24. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
Gearry RB; Roberts RL; Barclay ML; Kennedy MA
Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
[TBL] [Abstract][Full Text] [Related]
25. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.
Kader HA; Wenner WJ; Telega GW; Maller ES; Baldassano RN
J Clin Gastroenterol; 2000 Jun; 30(4):409-13. PubMed ID: 10875470
[TBL] [Abstract][Full Text] [Related]
26. Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs.
Jung YS; Cheon JH; Park JJ; Moon CM; Kim ES; Lee JH; Kim SW; Kim JH; Hong SP; Kim TI; Kim WH
J Hum Genet; 2010 Feb; 55(2):121-3. PubMed ID: 19960028
[TBL] [Abstract][Full Text] [Related]
27. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
[TBL] [Abstract][Full Text] [Related]
28. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA; Roberts RL; Kennedy MA
Aliment Pharmacol Ther; 2003 Aug; 18(4):395-400. PubMed ID: 12940924
[TBL] [Abstract][Full Text] [Related]
29. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
[TBL] [Abstract][Full Text] [Related]
30. Neutropenia related to an azathioprine metabolic disorder induced by an inosine triphosphate pyrophosphohydrolase (ITPA) gene mutation in a patient with PR3-ANCA-positive microscopic polyangiitis
.
Honda K; Kobayashi A; Niikura T; Hasegawa T; Saito Z; Ito S; Sasaki T; Komine K; Ishizuka S; Motoi Y; Kubota T; Yamamoto H; Yokoo T
Clin Nephrol; 2018 Nov; 90(5):363-369. PubMed ID: 30106365
[TBL] [Abstract][Full Text] [Related]
31. Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment.
Tsuchiya A; Aomori T; Sakamoto M; Takeuchi A; Suzuki S; Jibiki A; Otsuka N; Ishioka E; Kaneko Y; Takeuchi T; Nakamura T
Pharmazie; 2017 Jan; 72(1):22-28. PubMed ID: 29441893
[TBL] [Abstract][Full Text] [Related]
32. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.
Dong XW; Zheng Q; Zhu MM; Tong JL; Ran ZH
World J Gastroenterol; 2010 Jul; 16(25):3187-95. PubMed ID: 20593505
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease.
Suzuki S; Uchiyama K; Motoi Y; Yoshii Y; Inoue Y; Kubota T; Odahara S; Ohtaki Y; Takami S; Ito Z; Sato N; Ohkusa T; Koido S; Saruta M
BMC Gastroenterol; 2023 Jul; 23(1):239. PubMed ID: 37454061
[TBL] [Abstract][Full Text] [Related]
34. The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease.
Chisick L; Oleschuk C; Bernstein CN
Can J Gastroenterol; 2013 Jan; 27(1):39-43. PubMed ID: 23378982
[TBL] [Abstract][Full Text] [Related]
35. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
36. Influence of
Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
[TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
38. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics in inflammatory bowel disease.
Pierik M; Rutgeerts P; Vlietinck R; Vermeire S
World J Gastroenterol; 2006 Jun; 12(23):3657-67. PubMed ID: 16773681
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.
Davavala SK; Desai DC; Abraham P; Ashavaid T; Joshi A; Gupta T
Indian J Gastroenterol; 2014 Jan; 33(1):41-5. PubMed ID: 23996738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
